Chapter 243: Talent Pooling

In Songjiang District, Shanghai, a conference table is set up in a small-looking office. At this moment, around the conference table, there were seven or eight people sitting around. Although the office doesn't look very good, it can be said that these people are definitely elites in the eyes of ordinary people.

One of them, wearing thick-rimmed glasses and a slightly square face, is often referred to as the Chinese face, sitting in the middle of the conference table.

"Today, everyone finally came together, in this line, you may have heard of each other occasionally, but there are not many real opportunities to meet, I will first introduce them one by one, familiar with each other. ”

That's exactly what happened. Everyone nodded in unison.

The national character called Mr. Tu smiled: "Everyone will be a family in the future, don't be too angry." “

Glancing at a young man about thirty-five or sixteen years old on the right, he introduced to everyone: "This is Dr. Li Pingli, who has returned from studying at Harvard University in the United States, and has deep attainments in DNA cloning, genomic DNA cloning and protein purification.

"It turned out to be a disciple of Professor Nico, no wonder. Someone began to chimed in.

"That's the top talent in genomic DNA cloning, and we have such talent in our team, so we definitely don't have to talk about technology in this area in the future. “

After introducing Dr. Li Ping, everyone nodded to each other, smiled, said hello, and then began to introduce the next one.

This is Dr. Xu Fangxu of the NIH. ”

NIH refers to the National Institutes of Health, that is, the National Institutes of Health, which is one of the most important research institutions engaged in life science research in the world, and its share of the U.S. federal government's R&D funding is second only to the U.S. Department of Defense.

Mr. Tu introduced them one by one, and everyone found that everyone present seemed to have a gorgeous life experience.

The four people sitting on the left are from Harvard University, NIH, UCLA (University of California, Los Angeles), and the Chinese Academy of Sciences.

After introducing the scientific researchers on the left, it was the turn of the right, and there were only three people on the right.

"These four are all high-level researchers from well-known universities and scientific research institutions, and they will also be the heads of several branches of our company's R&D department in the future. As he spoke, Mr. Tu began to introduce the other three again.

"This one, who may not be familiar with scientific research, is Mr. Huang, deputy director of marketing of Novartis' oncology division. ”

The person called Mr. Huang stood up and nodded to everyone.

It doesn't sound like a good title, but if you know Novartis, you don't think so.

Novartis' name, derived from the Latin novae artes, and the Chinese name Novartis, which means commitment to China, is its company philosophy. That is, we are committed to improving the health and quality of life of Chinese people through continuous innovation of products and services.

Novartis is one of the world's three largest pharmaceutical companies, similar to Pfizer and Johnson & Johnson in the United States, and its eye care, vaccines and animal health products are world leaders. To be able to become the deputy marketing director of the oncology division of such a large company in China is definitely powerful.

"Today, it's a pleasure to meet you. Mr. Huang said simply, and then sat down.

"Well, Mr. Huang is still polite, we will all be a family in the future. Mr. Tu smiled and continued: "This is Liu Hui, the product manager of Merck China's life science department. “

This one is the product manager at Thermo Fisher Fisher. ”

Three people, the origin is not small, after all, the names of several companies are there, and being able to do the management position of these large companies, even if it is only the middle level, also shows their personal ability.

After the introduction, Mr. Tu said: "Actually, I have been thinking about this until this year, with the country's economic situation and the increase in investment in scientific research, I feel that I can't wait any longer." As we all know, I was not born in technology, but I still know a lot about this industry. With all these years of mixing in the circle, I can be regarded as having some connections, which can bring everyone here. ”

"Mr. Tu, I really want to thank you for this, if I hadn't contacted you, listening to what you said, I think this matter is promising, we probably have been staying in the laboratory as nerds. “

"Hahaha," Dr. Xu laughed. Mr. Tu laughed.

"Actually, I have also contacted many people, including the University of Hong Kong, NTU, University of Science and Technology of China, etc., and there are also teachers who are willing to join, but some are still under consideration, and some are also in the wait-and-see stage. Everyone can gather together today, which can be regarded as fate, and it is also to give me face for Tu Lin. My purpose is very simple, that is, to make money with the help of the state's investment. ”

"Or Mr. Tu said it simply. ”

"That's right, it's about making money. ”

"My hope is that you can work together in our team in the coming days to build the company into a world-class R&D and production enterprise of reagents, kits and consumables for biological and medical research as soon as possible. “

Mr. Tu spoke confidently and sonorously, then looked around and continued: "Not only that, but we also need to provide technical services for life science research and a one-stop procurement platform for laboratory equipment. With our top technology, the most mature products, and the most enthusiastic service, we serve the majority of scientific researchers and benefit life and health. “

"Mr. Tu said it well. ”

"That's the truth, we will definitely become bigger and stronger. ”

Although it was a bit like fighting chicken blood, a few scientific researchers who had never seen much of the marketing scene heard it and praised it in unison.

"At present, my plan is to specialize in life science products, starting with kits and consumables, and I think Dr. Li Ping Li is still responsible for specific technical issues. Mr. Tu said very solemnly, and looked at Li Ping with expectation in his eyes.

"The technical team is in charge of Dr. Li Ping, don't you have any opinions?" he glanced at the other people sitting around the conference table.

"In terms of technology, I believe that there is absolutely no problem with Dr. Li in charge, after all, he is under the tutelage of Professor NICO, and his reputation and technical strength are second to none. However, Dr. Zhang Fang of the University of Science and Technology of China was the matchmaker on my side, and at that time, it was also taking into account the reality of Mr. Tu, if you hadn't found me and asked me to introduce you, I don't think Dr. Zhang would have directly chosen to resign.

"Hehe, Mr. Huang, isn't it being discussed now, the company is in the initial stage, I believe that everyone's purpose is the same, that is, to be able to do things by themselves and no longer work for others. You chose to come out of Novartis, and I believe that's what you think. “

It is said that there is great power in numbers, but when creating a company, there are also disadvantages, that is, in terms of opinions, it is not easy to unify.

Of course, one of the most important points is that these technicians chose to agree to join at that time with certain conditions, such as which part they hope to be responsible for after the establishment of the company, or dividends at the end of the year in the form of shares. As the initiator Tu Lin, there is an obvious drawback.

That is, his relationship with these people is good, but the difficulty is that he is not an investor, so now it can only be negotiated in the name of negotiation, and there is no binding force.